TSR-033 structure
|
Common Name | TSR-033 | ||
---|---|---|---|---|
CAS Number | 2225940-96-3 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of TSR-033TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and PD-1 blocking activity in vitro and in vivo. TSR-033 has anti-tumor activity[1]. |
Name | TSR-033 |
---|
Description | TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and PD-1 blocking activity in vitro and in vivo. TSR-033 has anti-tumor activity[1]. |
---|---|
Related Catalog | |
In Vitro | TSR-033 (0.01-1000 nmol/L, 48 h) 可以增加原代人类 CD4 T细胞和树突状细胞的 IL2 产生,并增强T细胞效应器功能[1]。 |
In Vivo | TSR-033 (i.p.,10 mg/kg, twice weekly, 40 days) 在 A549 HuNOG-EXL NSCLC 小鼠肿瘤模型中,对肿瘤生长有中等程度的抑制作用,单独治疗终止时TGI 为 23%,而与 TSR-042 联合治疗有累积效应,能更大程度地阻碍肿瘤生长,终止时 TGI 为 45%[1]。 |
References |
No Any Chemical & Physical Properties |